CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target

Completed

Conditions studied: Type 2 Diabetes

In brief

This is a trial to determine if patients who are well controlled and on basal insulin are treated with excessive basal dose.

Key facts

Study ID

NCT01548222

Run by

Diabetes Care Center

People needed

20

Starts

2012-02-01

Expected to finish

2012-12-01

Last updated by the study team

2013-08-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes
• Age 18 years and above
• Concurrently on +/-thiazolidnedione +/-DDP IV inhibitors +/-metformin +/- glinides and basal insulin analogs
• A1C 10% or below
• Capable of self monitoring glucose at least 4 x a day
• Previously compliant with clinical recommendations
• Fasting blood glucose <110mg/dl average for 3 consecutive days
• BMI <45 kg/m

You may not qualify if…

• Urinary ketosis
• Current or expected alternation in insulin sensitivity such as major surgery, infection, renal failure, glucocorticoid treatment, recent serious hypoglycaemic episode
• Currently participating in another clinical trial
• Using rapid insulin insulin
• Pregnancy or nursing or the intention of becoming pregnant or not using adequate birth control
• Significant liver or heart failure.

Where it is running

• Diabetes Care Center — Salinas, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.